State of Wyoming’s LENZ Therapeutics LENZ Stock Holding History

State of Wyoming’s Portfolio LENZ Stock Details LENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,849	Closed	-$29.6K	–	2073
2025 Q4	$29.6K	Buy	+1,849	New	+$53.9K	﹤0.01%	1641
2023 Q3	–	Sell	-36	Closed	-$663	–	1850
2023 Q2	$663	Buy	36 +11	+44%	+$220	﹤0.01%	1523
2023 Q1	$436	Sell	25 -1	-4%	-$16	﹤0.01%	1552
2022 Q4	$614	Buy	26 +19	+271%	+$440	﹤0.01%	1519
2022 Q3	$0	Buy	+7	New	+$167	﹤0.01%	1992

Other funds holding LENZ

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

AWG

Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

7IH

72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

State of Wyoming's LENZ Position: Q1 2026 in Review

State of Wyoming sold out of LENZ Therapeutics (LENZ) in Q1 2026, closing a stake of 1,849 shares — an estimated $29.6K sold.

State of Wyoming first reported a position in LENZ in Q3 2022 and held it in 5 quarters. The position peaked at $29.6K in Q4 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

State of Wyoming reported no remaining LENZ Therapeutics position as of Q1 2026 after selling out during the quarter.
State of Wyoming sold 1,849 LENZ Therapeutics shares in Q1 2026, an estimated $29.6K.
State of Wyoming first reported a position in LENZ Therapeutics in Q3 2022 and held it in 5 quarters.
State of Wyoming's LENZ Therapeutics position peaked at $29.6K in Q4 2025.
145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.